Skip to content
Open access

Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study

Oct 2026 · International Journal of Molecular Sciences · Vol 27, pp. 9543 · 0 citations

TL;DR

AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.

Abstract

The gut microbiome has been proposed as a contributor to Alzheimer’s disease (AD) pathogenesis via the microbiota–gut–brain axis, but findings across cohorts are inconsistent and scarce data exist from Central Asian populations. We used shotgun metagenomic sequencing to compare the gut microbiome of AD patients and cognitively healthy controls from Kazakhstan. In a cross-sectional case–control study (35 AD, 39 Control), we profiled taxonomic and functional (HUMAnN pathway) composition, and compared alpha/beta diversity, individual taxa and pathways, and their association with clinical and demographic variables (Mann–Whitney U test, PERMANOVA/PERMDISP, OLS regression, all BH-FDR corrected, sensitivity analysis using ANCOM-BC2), with sensitivity analyses adjusting for age and BMI and applying Bonferroni correction. Within the AD group, circulating adiponectin—measured only in this group—was examined for associations with microbiome features in an exploratory analysis. Alpha diversity was lower in AD (q < 0.05). Community composition also separated by group on PERMANOVA (R2 = 8.6%, p = 0.001), and this separation held after adjusting for age and BMI. A total of 178 taxa differed significantly between groups (BH-FDR; 37 were also Bonferroni-significant), most prominently depletion of Faecalibacterium and enrichment of Eisenbergiella and Desulfovibrio in AD; 100 pathways differed significantly (20 Bonferroni-significant). Three clinical/demographic variables (total bilirubin, atherogenic index, BMI) were associated with specific taxa or pathways. Within the AD group, adiponectin correlated negatively with the pathway assimilatory sulfate reduction IV (rho = −0.60, q = 0.015). AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.

Read PDF

Similar papers

Open access Oct 2026

Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer’s disease clinical spectrum

Gut microbiome alterations have been associated with Alzheimer’s disease (AD), but how microbial composition, fecal metabolites, and cognitive function relate across the cognitive impairment spectrum—from subjective cognitive decline (SCD) through mild cognitive impairment (MCI) to AD—remains unclear. We integrated...

Yi Feng, Yao Sha, Lu-Lu Xu et al. · 0 citations
Open access Oct 2026

Altered gut microbiota and untargeted metabolomic features in patients with schizophrenia: a case–control study

Mental disorders are among the leading causes of global disease burden, and their etiology spans genetic, environmental, and physiological factors. Emerging evidence suggests that the gut microbiota may contribute to the development of neuropsychiatric disorders through the microbiota–gut–brain axis. This study aim...

Yun-Qiang Mi, Peng Sun, Qing-Rui Hao et al. · 0 citations
Open access Oct 2026

Change in gut microbiome precedes symptomatic Alzheimer's disease and is correlated with amyloid-beta accumulation in the brain

INTRODUCTION: Alzheimer's disease (AD) begins with cerebral amyloid-beta (A{beta}) deposition decades before clinical symptoms. While the microbiota-gut-brain axis has been implicated in AD, its role in this preclinical phase remains unclear. We examined potential links between gut microbiome features and presymptomati...

A. Shoubridge, S. Manning, S. Tan et al. · 0 citations
Review Open access Oct 2026

Microbiome-targeted strategies for Alzheimer’s disease: multi-omics signatures, mechanistic links, and intervention evidence

Alzheimer’s disease (AD) is increasingly studied in relation to gut microbial mechanisms because microbial metabolism, mucosal barrier function, and peripheral immune activation may influence neuroinflammation and host metabolic stress. This review evaluates microbiome-linked evidence in AD with emphasis on studies t...

Xu-Yang Huang, Xin-Yue Zhang, Qi Zhu · 0 citations
Review Open access Sep 2026

Gut–brain axis dysfunction in Parkinson’s disease: a meta-analysis of microbiome dysbiosis and intestinal barrier markers

The findings support a biologically plausible role for gut-related mechanisms in disease pathophysiology, with a preliminary signal for more pronounced involvement in gut-first PD phenotypes that remains to be confirmed.

Pulkit Mehrotra, K. Vengadakrishnan, Puneet Mehrotra et al. · 0 citations
Open access Oct 2026

Deciphering the microbiota-immune axis in adult-onset Still’s disease: evidence from Mendelian randomization and experimental evaluation

Objectives Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder with unclear etiology. Although gut microbiota may influence immune-mediated diseases, their genetically predicted associations with AOSD remain unclear. This study aims to investigate the potential associations between gut microbiota...

Chen-Lu Li, Fan Yang, Bin-Feng Wang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.